To advance structured Benefit-Risk Assessment (sBRA) by developing and promoting innovative visual analytics tools that enhance understanding, communication, and decision-making of benefit-risk assessment in the pharmaceutical and medical device industries.
| Develop and implement user-centric visualization techniques that transform complex sBRA data into accessible, actionable insights for efficient decision-making. |
| Standardize best practices for visual analytics in benefit-risk evaluation to ensure consistency and reliability. |
| Promote the adoption of visual analytics tools across regulatory bodies, industry professionals, and stakeholder. |
We encourage contributions and recommendations to Benefit Risk Decision Enhanced Visualizations. Please refer to the Contributions guide for more information on how you can contribute.